Benzenedodecanoic acid, α,α,4-trichloro- manufacturers
- K-111
-
- $293.00
-
2026-07-27
- CAS:221564-97-2
- Purity: 99.95%
- Supply Ability: 10g
|
| | Benzenedodecanoic acid, α,α,4-trichloro- Basic information |
| | Benzenedodecanoic acid, α,α,4-trichloro- Chemical Properties |
| Boiling point | 474.7±30.0 °C(Predicted) | | density | 1.199±0.06 g/cm3(Predicted) | | pka | 1.66±0.18(Predicted) |
| | Benzenedodecanoic acid, α,α,4-trichloro- Usage And Synthesis |
| Uses | K-111 (BM-170744) is an oral active PPAR alpha agonist. K-111 show efficacy in improving insulin resistance, reducing body weight, and ameliorating atherogenic dyslipidemia. K-111 can be used for study of type 2 diabetes, dyslipidaemia, obesity and the metabolic syndrome[1][2]. | | References | [1] Schfer SA, et al. Biochemical and morphological effects of K-111, a peroxisome proliferator-activated receptor (PPAR)alpha activator, in non-human primates. Biochem Pharmacol. 2004;68(2):239-251. DOI:10.1016/j.bcp.2004.03.004 [2] Ortmeyer HK, et al. Skeletal muscle glycogen synthase subcellular localization: effects of insulin and PPAR-alpha agonist (K-111) administration in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol. 2005;288(6):R1509-R1517. DOI:10.1152/ajpregu.00692.2004 |
| | Benzenedodecanoic acid, α,α,4-trichloro- Preparation Products And Raw materials |
|